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INTRODUCTION
Upper gastrointestinal (UGI) tract bleeding refers to
blood loss within the intraluminal gastrointestinal
tract from any location between the upper
oesophagus to the duodenum at the ligament of
Treitz . The onset and severity of blood loss can
range from intermittent and low-grade occult
bleeding presenting as occult blood positive stools
and iron deficiency anaemia to very abrupt and
massive blood loss presenting as haematemesis and
hypovolaemic shock . Acute gastrointestinal (GI)
bleeding is a potentially life-threatening abdominal
emergency that remains a common cause of
hospitalization. The incidence of UGI bleed is





approximately 100 cases per 100,000 population per
year . Bleeding from the UGI tract is approximately 4
times as common as bleeding from the lower GI tract
and is a major cause of morbidity and mortality.
Mortality rates from UGI bleed are 6-10% overall .
By convention, UGI bleeding has been categorized as
either variceal or nonvariceal in origin. Gastro-
oesophageal varices are enlarged venous collateral
channels that dilate as a consequence of portal
hypertension . Varices gradually enlarge and
eventually rupture, resulting in massive UGI
haemorrhage. In contrast, nonvariceal bleeding results
from disruption of oesophageal or gastroduodenal
mucosa with ulceration or erosion into an underlying
vessel. Some examples of nonvariceal lesions
responsible for UGI bleeding are Mallory-Weiss,
gastroduodenal ulcers or tumours, and Dieulafoy's
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Upper gastrointestinal tract bleeding refers to blood loss within the intraluminal gastrointestinal
tract from any location between the upper oesophagus to the duodenum at the ligament of Treitz. The onset and
severity of blood loss varies widely. Acute gastrointestinal bleeding is a potentially life-threatening abdominal
emergency that remains a common cause of hospitalization.
There is no local data on the clinical presentation, endoscopic findings and the risk factors for upper
gastrointestinal tract bleeding in Ilorin. This study was therefore to review the cases of upper gastrointestinal
tract bleed in Ilorin.
To review the cases of upper gastrointestinal tract bleeding seen in Ilorin.
A retrospective review of the cases of upper gastrointestinal tract bleeding who had upper
gastrointestinal tract endoscopy as part of their workup was undertaken to cover a eighteen month period from
June 2006 to November 2007. Their clinical presentation, endoscopic findings, and the risk factors which
predisposed them to bleeding were evaluated. The endoscopy register and the request forms were reviewed.
A total of thirty patients had upper gastrointestinal tract bleeding for which upper gastrointestinal tract
endoscopy was performed during the period under review. Twenty-three of the patients were males (76.7%)
while seven were females (23.3%). Sixteen patients (53.3%) presented with malaena only; eleven patients
(36.7%) with malaena and haematemesis only; while three patients (10.0%) presented with malaena,
haematemesis and haematochexia. However all the patients presented with malaena, haematemesis or
haematochexia. The commonest clinical presentation of patients with upper gastrointestinal tract bleeding
passage of malaena (53.3%). The commonest endoscopic finding was multiple sources of bleeding (66.7%)
while the commonest risk factor for upper gastrointestinal tract bleeding was NSAID use (36.7%).
The passage of malaena, multiple source of bleeding, and NSAID use are the commonest clinical
presentation, endoscopic findings and risk factors respectively in patients with upper gastrointestinal tract
bleeding in Ilorin. The spectrum of clinical presentation, endoscopic findings and risk factors for upper
gastrointestinal tract bleed found in this study is similar to that found by other workers
.
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Eyitayo hospital and maternity centre (EHMC), Ilorin
is a private hospital established in 1989 that runs a
specialist Gastroenterology clinic.It receives referrals
fo r G a s t r oe n t e r o l og y co ns u l t a t i o n s an d
oesophagogastroduodenoscopy(OGD) mainly from
the University of Ilorin Teaching Hospital (UITH)
Ilorin, other private hospitals, and other government-
owned primary and secondary health facilities in Ilorin
and its environs. This is because this procedure ie OGD
is not readily available elsewhere in Ilorin. Ilorin is
located in the North -central zone of Nigeria. It serves
patients from sub-urban and rural areas of Kwara state
as well as neighbouring states of Ekiti, Kogi, Niger,
Osun and Oyo. Ilorin also serves as the capital of
Kwara state, and it is multi-ethnic in composition .
The data obtained was entered into a computer using
SPSS version 10 statistical software for analysis.
At the conclusion of the study, a total of thirty patients
were found to have had upper GI bleed for which upper
GI endoscopy was carried out to evaluate them.
The ages of the patient ranged from 27-84years
with a mean of 53.3+/-15.2 years. Majority of the
patients were in the age group 50-59years ie sixth
decade of life. The peak age of the patients was the
sixth decade with a decline towards the ninth decade
(Table 1).
Twenty-three of the patients were males (76.7%)
while seven were females (23.3%) giving a male to
female ratio of 3.3:1 (Table 2).
From this study, 16 patients (53.3%) presented with
malaena only; 11 patients (36.7%) presented with
malaena and haematemesis only; while 3 patients
(10.0%) presented with malaena, haematemesis and
haematochexia. All the patients presented with
malaena alone or in combination with haematochexia
and or haematemesis. (Table 3) Bleeding duodenal
ulcer was seen in 40.0% of patients at endoscopy;
10.0% had gastric ulcer. Multiple source of bleeding
was found in 66.7% of patients; 26.7% had
oesophageal varices, 20.0% had erosive oesophagitis
while 6.7% had malignancy. NSAIDS use was seen in
36.7% of the patients; 6.7% of the patients on NSAIDS
also had background chronic liver disease; 13.3% had
chronic liver disease only; 20.0% were using alcoholic;
3.3% were on oral contraceptive use while 20.0% had
no risk factors for bleeding identified in them.From
this study, six patients (20.0%) had no risk factors for
UGI bleed identified in them.All the six patients
6
ulcer haemorrhage (25%), gastric ulcer
haemorrhage (20%), mucosal tears of the
oesophagus or fundus (Mallory-Weiss tear),
oesophageal varices, erosive gastritis, erosive
oesophagitis, Dieulafoy's lesion, gastric varices,
gastric cancer, and ulcerated gastric leimyoma . Rare
causes of UGI bleed include aortoenteric fistula,
gastric antral vascular ectasia, angiectasias, and
Osler-Weber-Rendu syndrome . The history and
physical examination provide crucial information
for the initial evaluation of a patient presenting with
a GI tract haemorrhage. The history findings can be
extremely helpful in determining the location of the
GI haemorrhage. Alcohol abuse or a history of liver
cirrhosis should elicit consideration of portal
gastropathy or oesophageal varices as a source of
bleeding. A history of recent nonsteroidal anti-
inflammatory drug (NSAID) abuse should elicit
concern about bleeding from a gastric ulcer .
Haematemesis is observed in 40-55% of patients,
including patients with coffee-ground emesis.
Malaena is documented in approximately 70-80% of
patients, and haematochezia in approximately 15-
20%. These clinical features may also be indicators
of the potential source of the GI bleeding . The
source of bleeding can be demonstrated via
oesophagogastroduodenoscopy. There is no local
data on the clinical presentation, endoscopic
findings and the risk factors for upper
gastrointestinal tract bleeding in Ilorin. This study
was therefore to review the cases of upper
gastrointestinal tract bleed in Ilorin.
The study was a hospital-based retrospective one. A
review of all patients seen with clinical features of
UGI bleed, and who underwent UGI endoscopy as
part of their work-up. The study covered a period of
eighteen-months between June 2006 and November
2007.The upper GI endoscope in use at the
endoscopy unit of the hospital is Olympus GIF
XQ10 model with an Olympus CLK 3-4 light source.
The patients were made to fast for 6-8 hours and had
10% plain xylocaine spray applied to the pharynx
before undergoing UGI endoscopy. All the patients
also had 20mg of intravenous hyoscine bromide
applied. Some of the patients who were found to be
anxious were given additional 10mg of intravenous
Diazepam. However none of the patients with
suspected or confirmed diagnosis of underlying liver
disease was given Diazepam. The presenting clinical
features as well as the risk factors predisposing to the
development of UGI bleed were noted. The data
obtained from these were analysed using a computer,
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Presentation Risk Factors
None Nsaids Alc Cld Cld&Nsaid Ocp Malig Total
Malaena 6 5 3 - - 1 1 16
Malaena&
Haematemesis - 2 2 4 2 - 1 11
Malaena,
Haematemesis&
Haematochezia - 2 1 - - - - 3
Total 6 9 6 4 2 1 2 30
presented with passage of malaena. Of the nine
patients(30.0%) with only NSAID use as risk factor
for UGI bleed, five of them presented with passage
of malaena, two of them presented with malaena and
haematemesis while the remaining two presented
with malaena, haematemesis and haematochezia. Of
all the six patients(20.0%) with alcohol use as risk
factors for UGI bleed; three of them presented
malaena; two of them with malaena and
haematochezia while one of them presented with
malaena, haematemesis and haematochezia. All the
four patients(13.3%) who had only CLD as the risk
factor for UGI bleed, presented with malaena and
haematemesis. The two patients(6.7%) who had
background CLD and NAID use as risk factors for
UGI bleed presented malaena and haematemesis.
The only patient (3.3%) with OCP use as a risk factor
for UGI bleed presented with malaena. Of the two
patients(6.7%) with oesophago-gastric malignancy
as risk factor for UGI bleed, one presented with
passage of malaena while the other presented with












Age groups (Years) Frequency Percent
Total 30 100
Sex Distribution of Patients.
Presentation of Bleeding.
Table 4:
NSAIDS= Nonsteroidal anti-inflammatory drugs
ALC= Alcohol
CLD= Chronic liver disease




Fiberoptic UGI endoscopy is now a well established
procedure for the investigation and management of
UGI disorders. It has become the procedure of choice
for its acceptability to the majority of patients, and for
its diagnostic superiority over barium studies . In
addition to being used as a diagnostic tool, the
endoscope has a role in therapeutic procedures . From
this study, 40.0% of the patients with UGI bleed had
duodenal ulcer at endoscopy while 10.0% had gastric
ulcer. This figure is comparable to the 37.5% for
duodenal ulcer found by Abdulazeez et al amongst
their patients with UGI bleed at endoscopy in the
Eastern province of Saudi Arabia. However the figure
is higher than the 17.3% for peptic ulcer found by Malu
et al amongst their patients with UGI bleed at
endoscopy in Zaria. It is lower than the 57.1% for
gastric and duodenal ulcerations found by
Voigtsberger et al amongst their German patients.
Arigbabu and Adekunle al found bleeding duodenal
ulcer as the commonest source of bleeding at
endoscopy in their patients in Ife. Multiple sources of
bleeding was found in 66.7% of patients at endoscopy
in this study. This is higher than the 15.4% found by
Voigtsberger et al . Abdulazeez did not find multiple
sources of bleeding. Lesions were found in all the
patients at endoscopy. This is similar to the findings of
Abdulazeez et al who found one lesion or the other in
all their bleeding patients. However Voigtsberger et al
could not find any lesion in 9.0% of their patients.From
this study, eight patients (26.7%) had oesophageal
varices. This figure is similar to the 26.5% found by
Abulazeez et al . It is however lower than the 34.6% for



















Malaena only 16 53.3
Malaena & Haematemesis only 11 36.7
Malaena & Haematemesis & Haematochexia 3 10.0
Malaena or Haematemesis or Haematochexia 30 100
Dougherty in their patients with UGI bleed. They
reported malaena in 70-80% of their patients;
haematemesis in 40-50%; haematochexia in 15-20%;
and haematochexia or malaena in 90-98% of them. A
review of the literature shows that there is no local data
from Ilorin with which to compare. Hence this study is
a pioneer one from Ilorin, and will serve as a baseline
for other researchers. Multi-centred studies involving
larger numbers of patients still need to be done.
The passage of malaena, multiple source of bleeding,
and NSAID use are the commonest clinical
presentation, endoscopic findings and risk factors
respectively in patients with upper gastrointestinal
tract bleeding in Ilorin. The spectrum of clinical
presentation, endoscopic findings and risk factors for
upper gastrointestinal tract bleed found in this study is
similar to that found by other workers. This study is a
pioneer one from Ilorin, and it will serve as a baseline
for other researchers.
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Oesophageal varices found by Malu et al . Out of the
eight cases of oesophageal varices, six were found to
be bleeding at endoscopy. All the patients with
bleeding oesophageal varices were found to be
Hepatitis B surface antigen (HBsAg) positive and all
had decompensating liver cirrhosis. The two patients
with nonbleeding oesophageal varices were cases of
decompensating alcoholic liver disease. At the time
of presentation, one was bleeding from a duodenal
ulcer rather than the varices while the other had
gastroduodenitis. Oesophageal varices are
manifestation of portal hypertension, and the most
common single aetiology of portal hypertension is
liver cirrhosis . Bleeding from oesophageal varices
account for one-third of all deaths in patients with
cirrhosis and portal hypertension . Prospective
studies have shown that up to 90% of patients with
cirrhosis will develop oesophageal varices . The
risk of bleeding from oesophagogastric varices is 25-
35% for both alcoholic and nonalcoholic cirrhosis
with the majority of initial bleeding episodes
occurring within the first year from the time of
diagnosis . Two of the patients (6.7%) with UGI
bleed had malignancy of the UGI tract (oesophageal
and gastric) at endoscopy. This is comparable to the
4.5% of Abdulazeez et al patients who had either
gastric or oesophageal cancer. Six patients (20.0%)
had reflux oesophagitis (erosive). This is higher than
the 2.0% found by Abdulazeez et al The variations
in the relative frequencies of the various lesions
found in the UGI tract at endoscopy between this
study and that of Abdulazeez et al , Malu et al ,
Voigtsberger et al and Arigbabu and Adekunle ,
might be due to the wide differences in sample size;
variations in geographical locations; ethnic, socio-
cultural, dietary and environmental factors. The
differences in the periods the studies were carried out
might also play a role. The commonest single lesion
at endoscopy was duodenal ulcer (40.0%). This may
be due to NSAID use because all the nine
patients(30.0%) with only NSAID as the risk factor
for UGI bleed had duodenal ulcer at endoscopy. This
is in contrast to oesophageal varices found in Zaria.
From this study, 36.7% of the patients were on
NSAIDS. NSAIDS are known to cause gastric
lesions and predispose to UGI bleed. In the study
by Atoba and Olubuyide , they found that there is
indiscriminate use of NSAIDS in Nigeria, and also
demonstrated that NSAIDS cause gastrointestinal
lesions which could lead to bleeding. From this study
also, 53.3% of the patients with UGI bleed presented
with malaena only; 36.7% with malaena and
haematemesis only; 10.0% with malaena,
haematemesis and haematochezia while all the
patients with UGI bleed presented with malaena or
haematemesis or haematochexia. This spectrum of
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